INTRODUCTIONPharmaceutical industry in the UKThe pharmaceutical industry in the UK directly employs around 72,000 people and in 2010 contributed £8.4 billion to GDP of the United Kingdom and has invested a total of £3.9 billion in research and development. In 2007, UK pharmaceutical exports totaled £14.6 billion, creating a pharmaceutical trade surplus of £4.3 billion. The United Kingdom is home to GlaxoSmithKline and AstraZeneca, the fifth and sixth largest global pharmaceutical companies, respectively, according to the 2010 market share. Foreign companies with a strong presence in the UK pharmaceutical industry include Pfizer, Novartis, Hoffmann-La Roche and Eisai. A fifth of the world's best-selling prescription drugs were developed in the UK. Research and development In 2012, the UK had the third highest share of global pharmaceutical R&D spending of any country, with 9% of the total, behind the United States (49%) and Japan (15%). The UK has the highest spending on pharmaceutical R&D of any European country, accounting for 23% of the total; followed by France (20%), Germany (19%) and Switzerland (11%). Pharmaceutical Industry in India The pharmaceutical industry in India is the third largest in the world in terms of volume. According to the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the total turnover of the Indian pharmaceutical industry between 2008 and September 2009 was US$ 21.04 billion. While the domestic market was worth $12.26 billion. The industry has a $14 billion market share in the United States. According to the Brand India Equity Foundation, the Indian pharmaceutical market is expected to grow at a compound annual growth rate (CAGR) of 14 to 17 percent between... ... middle of paper ......steroids, chelators iron, musculoskeletal, neuropsychiatry, nutritional and ophthalmic, oncology, respiratory, urology and women's health products in various dosage forms. It also provides veterinary products for various animals, including pets, equines, general care, livestock and poultry. Additionally, the Company offers inhaled medicines and devices, such as dry powder inhalers, single-dose and multi-dose dry powder capsule inhalers, breath-actuated metered dose inhalers, non-static spacers, baby masks and infants and nasal sprays. In addition, it provides consulting, commissioning, installation engineering, technical know-how transfer and support services. Cipla offers over 2,000 products across 65 therapeutic categories, available in over 40 dosage forms. Its key products include the following drugs: Escitalopram (antidepressant), Lamivudine, Fluticasone propionate..